Aprende enseñando Formación Profesional en el entorno sanitario

Esta memoria constituye el trabajo final del Máster Universitario en Profesorado en la especialidad de Formación Profesional. Para su elaboración he seguido las directrices de la guía docente de dicha asignatura. En él se recogen los aspectos más relevantes que he aprendido durante este curso, el marco teórico relativo a nuestra profesión docente y mi experiencia en el centro educativo durante los Prácticum. A partir de una selección de trabajos realizados durante el máster, he reflexionado sobre el proceso de aprendizaje, la integración de los saberes adquiridos en las diferentes asignaturas y adquisición de las competencias fundamentales para llegar a ser una buena profesional docente. Pero para llegar a serlo, hay que esforzarse y ser constante en el trabajo, teniendo en cuenta la formación continua a lo largo de la vida

PROGRAMA DE SALUD DIRIGIDO A PADRES Y ABUELOS CON EL OBJETIVO DE PREVENIR LA OBESIDAD INFANTIL INCIDIENDO EN LA ALIMENTACIÓN EN NIÑOS DE 0 A 2 AÑOS

Introducción: La obesidad infantil y juvenil constituye el trastorno nutricional de mayor relevancia en nuestro medio, siendo uno de los problemas sanitarios de mayor trascendencia. La rapidez con que se está incrementando su prevalencia hace que nos planteemos la necesidad de instaurar programas de educación nutricional. Objetivos: Elaborar un programa de educación para padres y abuelos con el fin de prevenir la obesidad infantil incidiendo en la alimentación del niño de 0 a 2 años. Metodología: A partir de la revisión bibliográfica se ha elaborado un programa de salud que refleja todos los aspectos sustanciales a tener en cuenta para mejorar las pautas de alimentación en niños de 0 a 2 años que serán enseñados a padres y abuelos. Desarrollo: El programa se ha estructurado en 5 sesiones con el fin de mejorar aspectos más concretos sobre la nutrición en los dos primeros años de vida, así como adquirir conocimientos y habilidades para mejorar la alimentación infantil y hábitos saludables. Conclusión: La elaboración de un programa de educación para la salud permitirá adquirir unos conocimientos básicos a los padres o familiares cercanos de niños de 0 a 2 años que puedan aplicar desde el nacimiento del niño y así reducir miedos e inseguridades a la hora de afrontar la situación. Palabras clave: “obesidad”, “obesidad infantil”, “prevalencia obesidad”, “prevención obesidad”, “sobrepeso-obesidad”, “prevención obesidad infantil”, “repercusión obesidad primeros años de vida”, “impacto social obesidad”, “lactancia materna”, “dietas”, “complicaciones obesidad”. ABSTRACT: Introduction: Child and adolescent obesity is the most important nutritional disorder in our country, having become one of the most significant health problems. The fast increase in its prevalence makes us consider the necessity to implement nutrition education programs. Goals: To develop an education program for parents and grandparents to prevent childhood obesity stressing the feeding of 0-2 years old infants. Methodology: On the base of the literature review, a health program has been developed which reflects all material aspects to be taken into account to improve eating patterns in children aged 0-2 years old who will be taught to parents and grandparents. Development: The program has been planned through five sessions so as to improve more specific aspects of nutrition in the first two years of life and acquire knowledge and skills to improve child nutrition and healthy habits. Conclusions: The development of a health education program will enable parents or close relatives of children of 0-2 years to acquire basic knowledge which will be applied from the birth of the child. Fears and insecurities will be reduced by the time they must face the situation. Key words: “obesity”, “childhood obesity”, “obesity prevalence”, “preventing obesity”, “overweight-obesity”, “childhood obesity prevention!, “obesity impact early life”, “social obesity impact”, “breastfeeding”, “diet”, “obesity complications”

Statin use and the risk of colorectal cancer in a population-based electronic health records study

There is extensive debate regarding the protective effect of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) on colorectal cancer (CRC). We aimed to assess the association between CRC risk and exposure to statins using a large cohort with prescription data. We carried out a case-control study in Catalonia using the System for Development of Primary Care Research (SIDIAP) database that recorded patient diseases history and linked data on reimbursed medication. The study included 25 811 cases with an incident diagnosis of CRC between 2010 and 2015 and 129 117 frequency-matched controls. Subjects were classified as exposed to statins if they had ever been dispensed statins. Analysis considering mean daily defined dose, cumulative duration and type of statin were performed. Overall, 66 372 subjects (43%) were exposed to statins. There was no significant decrease of CRC risk associated to any statin exposure (OR = 0.98; 95% CI: 0.95-1.01). Only in the stratified analysis by location a reduction of risk for rectal cancer was observed associated to statin exposure (OR = 0.87; 95% CI: 0.81-0.92). This study does not support an overall protective effect of statins in CRC, but a protective association with rectal cancer merits further research

The catalonia suicide risk code Epi-Study - A population-representative nested case-control study of suicide attempts in Catalonia, Spain

Introduction: Suicide attempts represent an important public health burden. Centralised electronic health record (EHR) systems have high potential to provide suicide attempt surveillance, to inform public health action aimed at reducing risk for suicide attempt in the population, and to provide data-driven clinical decision support for suicide risk assessment across healthcare settings. To exploit this potential, we designed the Catalonia Suicide Risk Code Epidemiology (CSRC-Epi) study. Using centralised EHR data from the entire public healthcare system of Catalonia, Spain, the CSRC-Epi study aims to estimate reliable suicide attempt incidence rates, identify suicide attempt risk factors and develop validated suicide attempt risk prediction tools. Methods and analysis: The CSRC-Epi study is registry-based study, specifically, a two-stage exposure-enriched nested case-control study of suicide attempts during the period 2014-2019 in Catalonia, Spain. The primary study outcome consists of first and repeat attempts during the observation period. Cases will come from a case register linked to a suicide attempt surveillance programme, which offers in-depth psychiatric evaluations to all Catalan residents who present to clinical care with any suspected risk for suicide. Predictor variables will come from centralised EHR systems representing all relevant healthcare settings. The study's sampling frame will be constructed using population-representative administrative lists of Catalan residents. Inverse probability weights will restore representativeness of the original population. Analysis will include the calculation of age-standardised and sex-standardised suicide attempt incidence rates. Logistic regression will identify suicide attempt risk factors on the individual level (ie, relative risk) and the population level (ie, population attributable risk proportions). Machine learning techniques will be used to develop suicide attempt risk prediction tools. Ethics and dissemination: This protocol is approved by the Parc de Salut Mar Clinical Research Ethics Committee (2017/7431/I). Dissemination will include peer-reviewed scientific publications, scientific reports for hospital and government authorities, and updated clinical guidelines

The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study)

Background: Severe cases of lymphopenia have been reported during siponimod clinical trials, which may negatively impact its benefit/risk profile. Objective: We aimed to evaluate the incidence of lymphopenia following the initiation of siponimod treatment in clinical practice. The secondary objectives included the analysis of factors predisposing to and the clinical relevance of lymphopenia events. Methods: In this multicenter retrospective cohort study, information collected from the medical records of 129 patients with MS from 15 tertiary hospitals in Spain who initiated treatment with Siponimod were followed-up for at least 3 months, including at least one lymphocyte count evaluation per patient. Results: Of the 129 patients, 121 (93.6%) reported lymphopenia events, including 110 (85.3%) with grade <= 3 and 11 (8.5%) with grade 4 lymphopenia, higher than those reported in the pivotal clinical trial (73.3% and 3.3% for grade <= 3 and grade 4 lymphopenia, respectively). The study included an unexpectedly high proportion of male subjects (72.9%), which might have led to an underestimation of the actual magnitude of the risk. Conclusions: In this study, the incidence and severity of lymphopenia after starting siponimod treatment were higher than those reported in previous clinical trials. Therefore, our results reinforce the need for the closer monitoring of novel MS drugs in clinical practice, as well as larger and longer follow-up studies to properly characterize this risk